Bridgeway Capital Management’s Dare Bioscience DARE Stock Holding History

Bridgeway Capital Management’s Portfolio DARE Stock Details DARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-1,689	Closed	-$165K	–	1429
2017 Q1	$165K	Hold	1,689	–	–	﹤0.01%	1301
2016 Q4	$144K	Hold	1,689	–	–	﹤0.01%	1341
2016 Q3	$207K	Hold	1,689	–	–	﹤0.01%	1315
2016 Q2	$430K	Buy	1,689 +834	+98%	+$267K	0.01%	1106
2016 Q1	$278K	Hold	855	–	–	﹤0.01%	1227
2015 Q4	$287K	Hold	855	–	–	0.01%	1208
2015 Q3	$376K	Buy	855 +137	+19%	+$68.9K	0.01%	1152
2015 Q2	$397K	Buy	+718	New	+$493K	0.01%	1172

Other funds holding DARE

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bridgeway Capital Management's DARE Position: Q2 2017 in Review

Bridgeway Capital Management sold out of Dare Bioscience (DARE) in Q2 2017, closing a stake of 1,689 shares — an estimated $165K sold.

Bridgeway Capital Management first reported a position in DARE in Q2 2015 and held it in 8 quarters. The position peaked at $430K in Q2 2016. 19 funds tracked by Wall St. Rank hold DARE as of Q2 2017.

Bridgeway Capital Management reported no remaining Dare Bioscience position as of Q2 2017 after selling out during the quarter.
Bridgeway Capital Management sold 1,689 Dare Bioscience shares in Q2 2017, an estimated $165K.
Bridgeway Capital Management first reported a position in Dare Bioscience in Q2 2015 and held it in 8 quarters.
Bridgeway Capital Management's Dare Bioscience position peaked at $430K in Q2 2016.
19 funds tracked by Wall St. Rank held Dare Bioscience as of Q2 2017.

Based on Bridgeway Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.